DTIL

MKT CAP:$181M

Precision BioSciences Inc

Market Cap

$181M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$6.50+$2.40 (+58.54%)

Jun 5, 2026

52W High $8.6152W Low $3.57

Company Details

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing...

CEO

—

IPO Date

Mar 28, 2019

Website

precisionbiosciences.com

Key Metrics TTM

Revenue

$45M

-11.9% YoY

Net Income

-$44M

EPS (Diluted)

Free Cash Flow

-$59M

Revenue / Share

$3.51

Gross Margin

97.0%

Operating Margin

-86.8%

Net Margin

-98.7%

FCF Margin

-130.4%

P/S

4.0x

P/E

Earnings Reports

Q1 2026

May 5, 2026

$11M+37272.4%

FY 2025

Mar 12, 2026

$34M-50.1%

Q4 2025

Mar 12, 2026

$34M+5261.1%

Q3 2025

Nov 3, 2025

$13.0K-97.7%

Q2 2025

Aug 7, 2025

$18.0K-100.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee